Bridging therapy prior to axicabtagene ciloleucel for relapsed/refractory large B-cell lymphomaChelsea C. Pinnix, Loretta J. Nastoupil, Sairah Ahmed et al.|Blood Advances|2020Cited by 224
Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphomaPaolo Strati, Sattva S. Neelapu, Sairah Ahmed et al.|Blood|2021Cited by 213
Hematopoietic recovery and immune reconstitution after axicabtagene ciloleucel in patients with large B-cell lymphomaPaolo Strati, Sattva S. Neelapu, Ankur Varma et al.|Haematologica|2020Cited by 148
Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphomaPaolo Strati, Tom Chi, Loretta J. Nastoupil et al.|Blood Advances|2020Cited by 114